Skip to content
Clinical Trials – home
LithuaniaBack to Lithuania

Clinical trials in Alytus

9 clinical trials in Alytus, Lithuania. Every trial is listed in the EU Clinical Trials Register and updated daily.

LithuaniaOur site in LithuaniaKlinikiniai-Tyrimai.lt(opens in a new tab)
Alytus at a glance
9
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

9 trials in Alytus

Open in trial search
Countries:LithuaniaLithuania
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:LithuaniaLithuania
  • Participants:18–64 years · 65+ years
  • Substances:Finerenone
  • Sponsor:Colorado Prevention Center
Countries:LithuaniaLithuania
  • Participants:18–64 years · 65+ years
  • Sponsor:Eli Lilly & Co.
Countries:LithuaniaLithuania
  • Participants:18–64 years · 65+ years
  • Sponsor:Amgen Inc.

Dyslipidaemia

Not recruiting
Registered drug
Countries:LithuaniaLithuania
  • Participants:18–64 years · 65+ years
  • Substances:Evolocumab
  • Sponsor:Amgen Inc.

Arteriosclerosis

Not recruiting
Registered drug
Countries:LithuaniaLithuania
  • Participants:18–64 years · 65+ years
  • Substances:Atorvastatin
  • Sponsor:Novartis Pharma AG

Ischaemic stroke+2

Not recruiting
Investigational
Countries:LithuaniaLithuania
  • Participants:18–64 years · 65+ years
  • Substances:Asundexian
  • Sponsor:Bayer AG

Arteriosclerosis

Not recruiting
Registered drug
Countries:LithuaniaLithuania
  • Participants:18–64 years · 65+ years
  • Substances:Inclisiran
  • Sponsor:Novartis Pharma AG
Countries:LithuaniaLithuania
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S

Other cities in Lithuania

The busiest research cities in the country

All 10 cities in Lithuania

Clinical research in Alytus

What the registry says about research in the country

01 Stroke Prevention Research

Groundbreaking research focusing on ischemic stroke prevention, particularly studying new therapeutic approaches for patients who have experienced acute non-cardioembolic strokes or high-risk transient ischemic attacks.

  • Post-stroke prevention strategies
  • Oral anticoagulation therapy
  • Mini-stroke management

Clinical investigations are evaluating novel oral medications combined with antiplatelet therapy for improved stroke prevention outcomes.

02 Cardiovascular Disease Management

Studies targeting atherosclerotic cardiovascular disease through innovative therapeutic approaches, focusing on reducing major adverse cardiovascular events in high-risk patients.

  • LDL-C level management
  • Cardiovascular death prevention
  • Heart attack risk reduction

Research aims to evaluate new treatments for preventing cardiovascular complications in patients with established vascular disease.

03 Heart Failure Research

Innovative clinical trials exploring treatments for acute decompensated heart failure, with special attention to patients with preserved and mildly reduced ejection fraction.

  • Heart failure event reduction
  • Cardiovascular mortality
  • Novel therapeutic approaches

Studies are evaluating new compounds to reduce heart failure events and improve patient outcomes.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.